{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:47:23Z","timestamp":1765356443385,"version":"3.37.3"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:00:00Z","timestamp":1536278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0203296","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T13:41:21Z","timestamp":1536327681000},"page":"e0203296","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings"],"prefix":"10.1371","volume":"13","author":[{"given":"Guoqing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"DeVos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Medina-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Wagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karidia","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Suzanne","family":"Beard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Du-Ping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Mwachari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Riwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boniface","family":"Jullu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngugi Evelyn","family":"Wangari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary S.","family":"Kibona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy W.","family":"Ng'Ang'A","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot","family":"Raizes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3331-0991","authenticated-orcid":true,"given":"Chunfu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,9,7]]},"reference":[{"year":"2017","key":"ref1","article-title":"Fact sheet\u2014Latest statistics on the status of the AIDS epidemic"},{"year":"2012","key":"ref2","article-title":"The HIV drug resistance report-2012"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/QAD.0b013e3283388742","article-title":"Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006","volume":"24","author":"WH Wheeler","year":"2010","journal-title":"Aids"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3851\/IMP2437","article-title":"Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review","volume":"18","author":"KM Stadeli","year":"2013","journal-title":"Antiviral therapy"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1473-3099(11)70149-9","article-title":"HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study","volume":"11","author":"RL Hamers","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/aid.2010.0030","article-title":"Transmitted HIV Type 1 Drug Resistance Among Individuals with Recent HIV Infection in East and Southern Africa","volume":"27","author":"MA Price","year":"2011","journal-title":"AIDS research and human retroviruses"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"e15510","DOI":"10.1371\/journal.pone.0015510","article-title":"Transmitted drug resistance in persons with acute\/early HIV-1 in San Francisco, 2002\u20132009","volume":"5","author":"V Jain","year":"2010","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"ref8","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/infdis\/jit111","article-title":"Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings","volume":"207","author":"V Cambiano","year":"2013","journal-title":"The Journal of infectious diseases"},{"key":"ref9","unstructured":"WHO. WHO HIV drug resistance report 20172017 March 11 2018:[1\u201382 pp.]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/255896\/1\/9789241512831-eng.pdf?ua=1\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/255896\/1\/9789241512831-eng.pdf?ua=1<\/ext-link>."},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/cid\/cix698","article-title":"Human Immunodeficiency Virus (HIV) Drug Resistance in African Infants and Young Children Newly Diagnosed With HIV: A Multicountry Analysis","volume":"65","author":"MR Jordan","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13104-016-2101-8","article-title":"Pre-treatment drug resistance among patients initiating antiretroviral therapy (ART) in Zimbabwe: 2008\u20132010","volume":"9","author":"M Mungati","year":"2016","journal-title":"BMC research notes"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S1473-3099(11)70216-X","article-title":"Time to get serious about HIV antiretroviral resistance","volume":"11","author":"E Wood","year":"2011","journal-title":"The Lancet Infectious Diseases"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1473-3099(11)70141-4","article-title":"HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review","volume":"11","author":"KC Sigaloff","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 2","key":"ref14","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/infdis\/jit121","article-title":"The Impact of HIV Drug Resistance on the Selection of First- and Second-Line ART in Resource-Limited Settings","volume":"207","author":"S Bertagnolio","year":"2013","journal-title":"The Journal of infectious diseases"},{"journal-title":"Lancet Infect Dis","article-title":"Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study","year":"2016","key":"ref15"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"ofy014","DOI":"10.1093\/ofid\/ofy014","article-title":"Human Immunodeficiency Virus-1 Drug Resistance Patterns Among Adult Patients Failing Second-Line Protease Inhibitor-Containing Regimens in Namibia, 2010\u20132015","volume":"5","author":"S Sawadogo","year":"2018","journal-title":"Open Forum Infectious Diseases"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/cid\/cir093","article-title":"Assessments of HIV drug resistance mutations in resource-limited settings","volume":"52","author":"MR Jordan","year":"2011","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref18","unstructured":"WHO. Global action plan for HIV drug resistance 2017\u20132021.2017 March 10 2018:[1\u201340 pp.]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/255883\/1\/9789241512848-eng.pdf?ua=1\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/255883\/1\/9789241512848-eng.pdf?ua=1<\/ext-link>."},{"issue":"Suppl 4","key":"ref19","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1093\/cid\/cis206","article-title":"Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004\u20132011","volume":"54","author":"MR Jordan","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref20","unstructured":"World Health Organization. World Health Organization protocol for cross sectional surveillance of acquired HIV drug resistance in populations failing first-line antiretroviral therapy. 2012."},{"key":"ref21","first-page":"17","article-title":"Role of the Laboratory in Ensuring Global Access to ARV Treatment for HIV-Infected Children: Consensus Statement on the Performance of Laboratory Assays for Early Infant Diagnosis","volume":"2","author":"W Stevens","year":"2008","journal-title":"OpenAIDS J"},{"key":"ref22","unstructured":"WHO. WHO Manual for HIV Drug Resistance Testing Using Dried Blood Spot Specimens, March 2010 2010 [cited 2012 January 17, 2012]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/topics\/drugresistance\/dbs_protocol.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/topics\/drugresistance\/dbs_protocol.pdf<\/ext-link>."},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/jac\/dkp353","article-title":"Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings","volume":"64","author":"A Johannessen","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/QAI.0b013e3181aeccbc","article-title":"Measure of viral load by using the Abbott Real-Time HIV-1 assay on dried blood and plasma spot specimens collected in 2 rural dispensaries in Cameroon","volume":"52","author":"AD Mbida","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"18","key":"ref25","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1097\/QAD.0b013e3281c618db","article-title":"High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients","volume":"21","author":"S Masciotra","year":"2007","journal-title":"AIDS"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1128\/JCM.00544-14","article-title":"Field Study of Dried Blood Spot Specimens for HIV-1 Drug Resistance Genotyping","volume":"52","author":"CM Parry","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"4","key":"ref27","first-page":"1107","article-title":"Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing","volume":"47","author":"M Monleau","year":"2009","journal-title":"JClinMicrobiol"},{"issue":"Supplement 3","key":"ref28","first-page":"A117","article-title":"Development and application of a broadly sensitive genotyping assay for surveillance of HIV-1 drug resistance in PEPFAR countries","volume":"13","author":"A McNulty","year":"2008","journal-title":"AntivirTher"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"e109060","DOI":"10.1371\/journal.pone.0109060","article-title":"Evaluation of dried blood spots collected on filter papers from three manufacturers stored at ambient temperature for application in HIV-1 drug resistance monitoring","volume":"9","author":"EK Rottinghaus","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/cid\/cis015","article-title":"Dried Blood Spot Specimens Are a Suitable Alternative Sample Type for HIV-1 Viral Load Measurement and Drug Resistance Genotyping in Patients Receiving First-Line Antiretroviral Therapy","volume":"54","author":"EK Rottinghaus","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref31","first-page":"195","article-title":"Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance","volume":"12","author":"S Bertagnolio","year":"2010","journal-title":"AIDS Rev"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/JCM.02347-12","article-title":"Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country","volume":"51","author":"S Inzaule","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QAI.0000000000001275","article-title":"Field Evaluation of Dried Blood Spots for HIV-1 Viral Load Monitoring in Adults and Children Receiving Antiretroviral Treatment in Kenya: Implications for Scale-up in Resource-Limited Settings","volume":"74","author":"ME Schmitz","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"year":"2013","key":"ref34","article-title":"Global report: UNAIDS report on the global AIDS epidemic 2013"},{"key":"ref35","unstructured":"Bank W. Antiretroviral therapy coverage 2013 [cited 2014 04\/06]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/data.worldbank.org\/indicator\/SH.HIV.ARTC.ZS\" xlink:type=\"simple\">http:\/\/data.worldbank.org\/indicator\/SH.HIV.ARTC.ZS<\/ext-link>."},{"key":"ref36","article-title":"Demonstrating the utility of dried blood spots for national surveillance of acquired HIVDR in Kenya","author":"G Zhang","year":"2014","journal-title":"Antiviral therapy"},{"key":"ref37","article-title":"High prevalence of L74V\/I mutations in Kenyan children with virologic failure","author":"E Rivadeneira","year":"2014","journal-title":"Antiviral therapy"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/INF.0000000000001597","article-title":"High Prevalence of Abacavir-associated L74V\/I Mutations in Kenyan Children Failing Antiretroviral Therapy","volume":"36","author":"EJ Dziuban","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"ref39","unstructured":"Biomerieux. NucliSens EasyQ HIV-1 v2.0 RUO Package Insert. 2010."},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"e28184","DOI":"10.1371\/journal.pone.0028184","article-title":"Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings","volume":"6","author":"Z Zhou","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/JCM.06689-11","article-title":"Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool","volume":"50","author":"CK Woods","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.meegid.2013.04.032","article-title":"Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools","volume":"19","author":"AC Pineda-Pena","year":"2013","journal-title":"Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases"},{"key":"ref43","unstructured":"Hall TA, editor BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT. Nucleic acids symposium series; 1999."},{"key":"ref44","first-page":"41","article-title":"HIV-1 subtype and circulating recombinant form (CRF) reference sequences, 2005","volume":"2005","author":"T Leitner","year":"2005","journal-title":"HIV sequence compendium"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/JCM.01567-07","article-title":"Clinical evaluation of NucliSENS magnetic extraction and NucliSENS analyte-specific reagents for real-time detection of human metapneumovirus in pediatric respiratory specimens","volume":"46","author":"CC Ginocchio","year":"2008","journal-title":"Journal of clinical microbiology"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"e39455","DOI":"10.1371\/journal.pone.0039455","article-title":"Evaluation of four different systems for extraction of RNA from stool suspensions using MS-2 coliphage as an exogenous control for RT-PCR inhibition","volume":"7","author":"LM Shulman","year":"2012","journal-title":"PLoS One"},{"key":"ref47","unstructured":"World Health Organization. Guidance on regulations for the Transport of Infectious Substances 2013\u20132014. International Health Regulations Coordination, World Health Organization, Geneva, Switzerland <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www\/who\/int\/ihr\/publications\/who_hse_ihr_20100801_enpdf2012\" xlink:type=\"simple\">http:\/\/www\/who\/int\/ihr\/publications\/who_hse_ihr_20100801_enpdf2012<\/ext-link>."},{"issue":"8","key":"ref48","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/jac\/dkq205","article-title":"Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping","volume":"65","author":"M Monleau","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref49","unstructured":"World Health Organization. Surveillance of HIV drug resistance in adults receiving ART (acquired HIV drug resistance): concept note. 2014."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0203296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:26:00Z","timestamp":1588965960000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0203296"}},"subtitle":[],"editor":[{"given":"Dimitrios","family":"Paraskevis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,7]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0203296","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,9,7]]}}}